| Title | AN OPEN-LABEL EXTENSION (OLE) STUDY TO EVALUATE THE EFFICACY AND SAFETY OF NEFECON TREATMENT IN PATIENTS WITH IGA NEPHROPATHY WHO HAVE COMPLETED STUDY NEF-301 |
|---|---|
| Description | The primary objectives are to assess the effect of 9 months of retreatment with Nefecon on urine protein to creatinine ratio (UPCR) and estimated glomerular filtration rate (eGFR) in patients who completed Study Nef-301 with Nefecon treatment; and to assess the effect of 9 months of treatment with Nefecon on UPCR and eGFR in patients who completed Study Nef-301 with placebo treatment. |
| Organism | Homo sapiens |
| Data Type | Clinical Research data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA010618 |
| Release Date | 2026-01-30 |
| Submitter | Ziwei Yang (v-ziwei.yang@everestmedicines.com) |
| Organization | Everest Medicines |
| Submission Date | 2022-07-19 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download |
|---|---|---|---|---|---|---|
| OMIX001310-01 | screening clinical data for ES103002 | 58 | Clinical Research data | 3.9 MB | Controlled | |
| OMIX001310-02 | visit clinical data for ES103002 | 58 | Clinical Research data | 10.4 MB | Controlled |
| Paper Title | Journal Name | Publish Time | Accession | Citing Type |
|---|